Literature DB >> 10851090

No requirement for src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen.

M A Broome1, S A Courtneidge.   

Abstract

A growing body of literature suggests that the ubiquitously expressed Src family kinases (Src, Fyn and Yes) are required for agents such as platelet-derived growth factor (PDGF) to stimulate DNA synthesis. Yet Klinghoffer and colleagues recently presented evidence that fibroblasts derived from mice null for Src, Fyn and Yes responded normally to PDGF (Klinghoffer et al., 1999, EMBO J., 18: 2459 - 2471). What is the reason for this discrepancy? We noted that Klinghoffer et al. (1999) used SV40 large T antigen (largeT) to facilitate derivation of cell lines from the embryos. We therefore tested the effect of largeT on PDGF receptor signaling. We found that expression of largeT overcame the inhibitory effects of interfering forms of both Ras (N17Ras) and Src (SrcK-). Furthermore, injection of SrcK- or the cst.1 antibody (which inhibits Src, Fyn and Yes) failed to inhibit PDGF-stimulated DNA synthesis in NIH3T3 cells expressing dominant negative p53, and fibroblasts derived from p53 null embryos. These data suggest firstly that caution should be used in interpretation of experiments conducted in cell lines expressing largeT, and secondly that the role of Src family kinases in growth factor signaling may be to oppose the effects of negative growth regulators such as p53. Oncogene (2000) 19, 2867 - 2869

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10851090     DOI: 10.1038/sj.onc.1203608

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  RACK1 regulates G1/S progression by suppressing Src kinase activity.

Authors:  Vidya Mamidipudi; Jian Zhang; Kelly C Lee; Christine A Cartwright
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

3.  The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors.

Authors:  Mélanie Franco; Olivia Furstoss; Valérie Simon; Chrsitine Benistant; Wan Jing Hong; Serge Roche
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

4.  Malignant transformation but not normal cell growth depends on signal transducer and activator of transcription 3.

Authors:  Karni Schlessinger; David E Levy
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

5.  c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis.

Authors:  Olivia Furstoss; Karel Dorey; Valérie Simon; Daniela Barilà; Giulio Superti-Furga; Serge Roche
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

6.  Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis.

Authors:  T Bowman; M A Broome; D Sinibaldi; W Wharton; W J Pledger; J M Sedivy; R Irby; T Yeatman; S A Courtneidge; R Jove
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

7.  Divergent roles of c-Src in controlling platelet-derived growth factor-dependent signaling in fibroblasts.

Authors:  Kavita Shah; Fabien Vincent
Journal:  Mol Biol Cell       Date:  2005-08-31       Impact factor: 4.138

8.  v-Src-induced modulation of the calpain-calpastatin proteolytic system regulates transformation.

Authors:  N O Carragher; M A Westhoff; D Riley; D A Potter; P Dutt; J S Elce; P A Greer; M C Frame
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

9.  Role of Stat3 in regulating p53 expression and function.

Authors:  Guilian Niu; Kenneth L Wright; Yihong Ma; Gabriela M Wright; Mei Huang; Rosalyn Irby; Jon Briggs; James Karras; W Douglas Cress; Drew Pardoll; Richard Jove; Jiangdong Chen; Hua Yu
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

10.  MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro.

Authors:  Manuela Quintavalle; Leonardo Elia; Gianluigi Condorelli; Sara A Courtneidge
Journal:  J Cell Biol       Date:  2010-03-29       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.